永信強攻日本 抗癌針劑 收購日商CHEMIX

永信收購CMX股權發展針劑、抗腫瘤藥品楊伶雯2013年6月3日 19:14 記者楊伶雯／台北報導 永信投控3日宣布已在5月31日簽約，收購日本法人株式會社CHEMIX（簡稱CMX）100%股權，CMX在收購完成後將成為永信旗下子公司，未來將結合CMX優勢，除將針劑、抗腫瘤藥品等列為未來發展重心外，將加速學名藥品的開發。永信集團於1965年創立，旗下成員包含台灣永信藥品、永日化學、永信東南亞控股、中國永信(昆山)、美國CTI等藥品與原料廠，具有超過400種學名藥與其相關原料藥開發，生產及銷售的豐富經驗，台灣永信藥品2009年完成歐盟PICS/GMP系統相關的建構，全廠區包含無菌與非無菌製劑也通過日本厚生省對醫藥品外國製造業者的查核與認證。CMX在1987年成立，2012年營業規模近20億日幣，業務以銷售進口針劑藥品與原料藥為主，於山梨縣備有先進之檢驗實驗室、分包裝線與倉儲物流中心，並具有超過20年的日本藥品與原料藥查驗登記經驗，與多家大型日本藥廠及通路商有緊密的策略合作關係。 永信表示，原任CMX社長吉岡義篤將續任社長職務，協助經營至屆齡退休；這件收購案永信將結合CMX優勢，除將針劑、抗腫瘤藥品等列為未來發展重心外，將結合集團內、外具有國際競爭力的原料藥與製劑夥伴加速學名藥品開發，持續擴大CMX與日本藥廠及通路商的合作爭取全球龐大的學名藥商機。 永信說，透過CMX平台，將更多高品質的日本產品輸出到集團各公司的據點，營造最大的綜合效益。

Generic products

Chemix has jointly accomplished the development of many generic products with the world leading pharmaceutical companies since its inauguration. Chemix has marketed and sold excellent generic products manufactured in foreign countries.

APIs, bio-products and health food materials

Chemix has introduced APIs from around the world into Japanese pharmaceutical companies. Chemix has played an active role for foreign manufacturers as a domestic care taker of Japanese DMF and Accreditation of Foreign Manufactures (AFM). Chemix imports and sells bio-products to research centers, universities and bio-technology companies. Chemix imports and sells high-quality functional food materials that conform to the GMP level of drugs.

Since Chemix' inauguration in 1987, Chemix has been importing APIs from various overseas countries and selling them to pharmaceutical companies in Japan that is second largest market in the world. Chemix has been collaborating with researchers of foreign pharmaceutical companies to develop APIs and successfully introduces them to Japanese pharmaceutical companies. Chemix has a long experience registering foreign manufacturers' Japanese DMF and its accreditation license ( AFM), that enable to sell APIs in Japan, that will be maintained by Chemix' overseas regulation to extend their license for future, too. Bio-products such as albumin isolated from caw blood are also imported to sell to bio-companies for research purpose and commercial production as well. Chemix imports natural extracts for health food industry. Japanese market size in health products is getting larger and larger every years. Chemix recognizes that just as medical products are used for the treatment of disease and injuries and functional foods such as natural extracts are important items to backup daily health promotion.